Trimethoprim-sulfamethoxazole induced circulatory shock in a human immunodeficiency virus uninfected patient: a case report and review.
Patricia LiuGregory P RanchesJeffrey A GoldPublished in: BMC pharmacology & toxicology (2018)
TMP-SMX can rarely result in a severe, non-anaphylactic circulatory shock; if initially unrecognized, patients may undergo repeat drug exposure with an associated high morbidity risk. While more commonly reported in HIV individuals, this case demonstrates that TMP-SMX related circulatory shock can occur in a HIV negative patient.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv infected
- hepatitis c virus
- hiv positive
- hiv aids
- end stage renal disease
- extracorporeal membrane oxygenation
- case report
- hiv testing
- drug induced
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- high glucose
- early onset
- south africa
- patient reported outcomes
- microbial community
- electronic health record
- adverse drug